Myc is implicated in the control of growth in a variety of cell types. I investigated c-myc gene expression in several lymphoid cell lines to determine the response to cyclic AMP. Cyclic AMP causes a precipitous decline in c-myc message concentration that precedes G1 cell cycle arrest in wild type S49 cells but not in KIN- cells that lack cAMP dependent PKA activity. In wild-type S49 cells washout of cyclic AMP restores c-myc message levels within 2 h but does not relieve the G1 arrest until 10 h later. Transcription runoff studies demonstrate inhibition of both transcriptional initiation and prolongation of initiated transcripts. However, the degree of inhibition is insufficient to explain the absence of detectable myc message suggesting that the predominant effect of cyclic AMP is to destabilize the c-myc message. In contrast to wild-type cells, the "Deathless" mutant S49 cell line is viable when arrested in G1 by exposure to cyclic AMP and has preserved c-myc expression. Thus, in S49 cells down regulation of c-myc expression appears to be associated with loss of viability rather than G1 cell cycle arrest. Interestingly, CEM human T lymphoma cells do not arrest in G1 phase when exposed to cyclic AMP in spite of losing detectable c-myc gene expression. This suggests that in some T lymphoma cells c-myc gene expression may not be necessary for cell cycle progression and proliferation.
D A Albert
Title and authors | Publication | Year |
---|---|---|
Targeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphoma
F Murray, PA Insel |
Expert Opinion on Therapeutic Targets | 2013 |
Quantitative Proteomics Analysis of the cAMP/Protein Kinase A Signaling Pathway
Y Guo, A Wilderman, L Zhang, SS Taylor, PA Insel |
Biochemistry | 2012 |
Gene Expression Signatures of cAMP/Protein Kinase A (PKA)-promoted, Mitochondrial-dependent Apoptosis: COMPARATIVE ANALYSIS OF WILD-TYPE AND cAMP-DEATHLESS S49 LYMPHOMA CELLS
L Zhang, AC Zambon, K Vranizan, K Pothula, BR Conklin, PA Insel |
The Journal of biological chemistry | 2007 |
Involvement of DNA-dependent protein kinase in regulation of the mitochondrial heat shock proteins
JH Um, CD Kang, BW Hwang, MY Ha, JG Hur, DW Kim, BS Chung, SH Kim |
Leukemia Research | 2003 |
Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells
N Kvirkvelia, I Vojnovic, TD Warner, V Athie-Morales, P Free, N Rayment, BM Chain, TW Rademacher, T Lund, IM Roitt, PJ Delves |
Clinical & Experimental Immunology | 2002 |
8-Cl-adenosine mediated cytotoxicity and sensitization of T-lymphoblastic leukemia cells to TNFα-induced apoptosis is via inactivation of NF-κB
Y Yin, PD Allen, L Jia, SM Kelsey, AC Newland |
Leukemia Research | 2001 |
Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure
L Barlucchi, A Leri, DE Dostal, F Fiordaliso, H Tada, TH Hintze, J Kajstura, B Nadal-Ginard, P Anversa |
Circulation research | 2001 |
Cyclic AMP- and IL6-Signaling Cross Talk: Comodulation of Proliferation and Apoptosis in the 7TD1 B Cell Hybridoma
BJ Irvin, CL Hanson, LH Smith, CK Daniels |
Experimental Cell Research | 2001 |
Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance
JH Um, CD Kang, BG Lee, DW Kim, BS Chung, SH Kim |
Oncogene | 2001 |
Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha
Y Yin, PD Allen, L Jia, MG Macey, SM Kelsey, AC Newland |
British Journal of Haematology | 2000 |
Infection of CD4 + Memory T Cells by HIV-1 Requires Expression of Phosphodiesterase 4
Y Sun, L Li, F Lau, JA Beavo, EA Clark |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
Angiotensin-Converting Enzyme–Independent Contraction to Angiotensin I in Human Resistance Arteries
N Padmanabhan, AG Jardine, JC McGrath, JM Connell |
Circulation | 1999 |
Angiotensin Production by the Heart: A Quantitative Study in Pigs With the Use of Radiolabeled Angiotensin Infusions
JP van Kats, AH Danser, JR van Meegen, LM Sassen, PD Verdouw, MA Schalekamp |
Circulation | 1998 |
Differential Regulation of Cardiac Angiotensin Converting Enzyme Binding Sites and AT 1 Receptor Density in the Failing Human Heart
LS Zisman, K Asano, DL Dutcher, A Ferdensi, AD Robertson, M Jenkin, EW Bush, T Bohlmeyer, MB Perryman, MR Bristow |
Circulation | 1998 |
Human Vascular Renin-Angiotensin System and Its Functional Changes in Relation to Different Sodium Intakes
M Boddi, L Poggesi, M Coppo, N Zarone, S Sacchi, C Tania, GG Serneri |
Hypertension | 1998 |
Localization and Production of Angiotensin II in the Isolated Perfused Rat Heart
LM de Lannoy, AH Danser, AM Bouhuizen, PR Saxena, MA Schalekamp |
Hypertension | 1998 |
Inhibiting Tissue Angiotensin-Converting Enzyme: A Pound of Flesh Without the Blood?
LS Zisman |
Circulation | 1998 |
In Vitro and in Vivo Anti-Leukemic Efficacy of Cyclic AMP Modulating Agents Against Human Leukemic B-cell Precursors
DE Myers, M Chandan-Langlie, LM Chelstrom, FM Uckun |
Leukemia & Lymphoma | 1996 |
Evidence for the Existence of a Functional Cardiac Renin-Angiotensin System in Humans
GG Serneri, M Boddi, M Coppo, T Chechi, N Zarone, M Moira, L Poggesi, M Margheri, I Simonetti |
Circulation | 1996 |